Basal Insulin Market is Forecasted to Hit USD 30.5 Billion Driven by Long-Acting Formulations
The global basal insulin market is expected to reach USD 44,659 million by 2035, up from USD 18,893 million in 2024. During the forecast period 2025 to 2035, the industry is projected to register at a CAGR of 8.3%, driven by the increasing burden of Type 2 diabetes, patient-friendly once-daily dosing, and advancements in long-acting analogs such as degludec and glargine. Enhanced delivery...
0 Comments 0 Shares 19 Views 0 Reviews
Sponsored